Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANIDULAFUNGIN vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANIDULAFUNGIN vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED: Safety Overview

Metric ANIDULAFUNGIN ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED
Total FAERS Reports 701 494
Deaths Reported 325 51
Death Rate 46.4% 10.3%
Hospitalizations 287 109
Average Patient Age 53.3 yrs 32.9 yrs
% Female Patients 40.0% 4.7%
FDA Approval Date Feb 17, 2006 N/A
Manufacturer Roerig N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A